Tandem Diabetes Care Inc  

(Public, NASDAQ:TNDM)   Watch this stock  
Find more results for Lonnie D. Morrison
0.00 (0.00%)
Mar 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 10.75 - 22.64
Open     -
Vol / Avg. 7,805.00/244,280.00
Mkt cap 374.72M
P/E     -
Div/yield     -
EPS -3.40
Shares 29.69M
Beta     -
Inst. own 61%
May 21, 2015
Tandem Diabetes Care Inc Annual Shareholders Meeting (Estimated) - 6:00PM EDT - Add to calendar
May 4, 2015
Q1 2015 Tandem Diabetes Care Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 3, 2015
Tandem Diabetes Care Inc at Cowen Health Care Conference
Feb 24, 2015
Q4 2014 Tandem Diabetes Care Inc Earnings Call - Webcast
Feb 24, 2015
Q4 2014 Tandem Diabetes Care Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -103.23% -159.94%
Operating margin -97.85% -152.17%
EBITD margin - -143.32%
Return on average assets -66.42% -59.20%
Return on average equity -121.37% -93.50%
Employees 324 -
CDP Score - -


11045 Roselle St Ste 200
SAN DIEGO, CA 92121-1231
United States - Map
+1-858-3666900 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Tandem Diabetes Care, Inc. is a medical device company with an approach to design, develop and commercialize products for people with insulin-dependent diabetes. The Company designed and commercialized its flagship product, the t:slim Insulin Delivery System, or t:slim, based on its technology platform and consumer-focused approach. Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump�s cartridge rather than relying on a syringe and plunger mechanism. The t:slim also features an embedded software architecture, a vivid color touch screen and a micro-USB connection that supports both a rechargeable battery and t:connect, its data management software. It also applies the science of human factors to its design and development process, which seeks to optimize its devices to the intended users, allowing users to operate the devices in their intended environment.

Officers and directors

Lonnie M. Smith Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Kim D. Blickenstaff President, Chief Executive Officer, Board Member
Age: 61
Bio & Compensation  - Reuters
John Cajigas Chief Financial Officer, Treasurer
Age: 47
Bio & Compensation  - Reuters
John F. Sheridan Chief Operating Officer, Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Bob Anacone Executive Vice President, Chief Commercial Officer
Age: 63
Bio & Compensation  - Reuters
Susan M. Morrison Chief Administrative Officer
Age: 34
Bio & Compensation  - Reuters
David B. Berger Esq. General Counsel
Age: 44
Bio & Compensation  - Reuters
Dick P. Allen Independent Director
Age: 69
Bio & Compensation  - Reuters
Edward L. Cahill Independent Director
Age: 61
Bio & Compensation  - Reuters
Fred E. Cohen Ph.D., M.D. Independent Director
Age: 57
Bio & Compensation  - Reuters